Research ExplorerPublicationsIs Myrtol® Standardized a New Alternative toward Antibiotics...

Is Myrtol® Standardized a New Alternative toward Antibiotics?

Standard

Is Myrtol® Standardized a New Alternative toward Antibiotics? / Paparoupa, Maria; Gillissen, Adrian.

In: Pharmacogn Rev, Vol. 10, No. 20, 14.01.2017, p. 143-146.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Paparoupa, M & Gillissen, A 2017, 'Is Myrtol® Standardized a New Alternative toward Antibiotics?', Pharmacogn Rev, vol. 10, no. 20, pp. 143-146. https://doi.org/10.4103/0973-7847.194045

APA

Paparoupa, M., & Gillissen, A. (2017). Is Myrtol® Standardized a New Alternative toward Antibiotics? Pharmacogn Rev, 10(20), 143-146. https://doi.org/10.4103/0973-7847.194045

Vancouver

Paparoupa M, Gillissen A. Is Myrtol® Standardized a New Alternative toward Antibiotics? Pharmacogn Rev. 2017 Jan 14;10(20):143-146. https://doi.org/10.4103/0973-7847.194045

Bibtex

@article{44e616d117f240ebac716664572095e9,
title = "Is Myrtol{\textregistered} Standardized a New Alternative toward Antibiotics?",
abstract = "GeloMyrtol({\textregistered}) and GeloMyrtol({\textregistered}) forte, also known as Myrtol({\textregistered}) standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. The major biological marker of in vivo and ex vivo activity of Myrtol({\textregistered}) standardized is the monoterpenes, d-limonene, 1,8-cineole, and alpha-pinene. Myrtol({\textregistered}) standardized is estimated to have antioxidative, anti-inflammatory, and antibacterial potential while many studies confirmed its secretolytic and bronchospasmolytic effects. As such, the medication is proposed to be initiated in several acute and chronic infections of the upper and lower airway system as acute and chronic rhinosinusitis, acute and chronic bronchitis, and chronic obstructive pulmonary disease. This review intends to give an insight into several prescription indications of Myrtol({\textregistered}) standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain.",
keywords = "Review, Journal Article",
author = "Maria Paparoupa and Adrian Gillissen",
year = "2017",
month = jan,
day = "14",
doi = "10.4103/0973-7847.194045",
language = "English",
volume = "10",
pages = "143--146",
journal = "Pharmacogn Rev",
issn = "0973-7847",
publisher = "Wolters Kluwer Medknow Publications",
number = "20",

}

RIS

TY - JOUR

T1 - Is Myrtol® Standardized a New Alternative toward Antibiotics?

AU - Paparoupa, Maria

AU - Gillissen, Adrian

PY - 2017/1/14

Y1 - 2017/1/14

N2 - GeloMyrtol(®) and GeloMyrtol(®) forte, also known as Myrtol(®) standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. The major biological marker of in vivo and ex vivo activity of Myrtol(®) standardized is the monoterpenes, d-limonene, 1,8-cineole, and alpha-pinene. Myrtol(®) standardized is estimated to have antioxidative, anti-inflammatory, and antibacterial potential while many studies confirmed its secretolytic and bronchospasmolytic effects. As such, the medication is proposed to be initiated in several acute and chronic infections of the upper and lower airway system as acute and chronic rhinosinusitis, acute and chronic bronchitis, and chronic obstructive pulmonary disease. This review intends to give an insight into several prescription indications of Myrtol(®) standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain.

AB - GeloMyrtol(®) and GeloMyrtol(®) forte, also known as Myrtol(®) standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. The major biological marker of in vivo and ex vivo activity of Myrtol(®) standardized is the monoterpenes, d-limonene, 1,8-cineole, and alpha-pinene. Myrtol(®) standardized is estimated to have antioxidative, anti-inflammatory, and antibacterial potential while many studies confirmed its secretolytic and bronchospasmolytic effects. As such, the medication is proposed to be initiated in several acute and chronic infections of the upper and lower airway system as acute and chronic rhinosinusitis, acute and chronic bronchitis, and chronic obstructive pulmonary disease. This review intends to give an insight into several prescription indications of Myrtol(®) standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain.

KW - Review

KW - Journal Article

U2 - 10.4103/0973-7847.194045

DO - 10.4103/0973-7847.194045

M3 - SCORING: Review article

C2 - 28082798

VL - 10

SP - 143

EP - 146

JO - Pharmacogn Rev

JF - Pharmacogn Rev

SN - 0973-7847

IS - 20

ER -